Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Roger Mathias who wrote (2590)	10/3/1998 8:13:00 AM
From: Tim K	Read Replies (1) \| Respond to of 3702

I've wondered about NIH involvement for some time now. It is their catheter system being used for the glioma trials, and I think I read that it may be used for other TNT trials as well. They may already be supporting the trials in some way. I would hope that when there is good news to announce about success in the trials they will help spread the word, since the media and seems to be more willing to believe and tell the world about news when it comes from the government than from private companies. I guess there are more taxpayers than shareholders and patients. There is a lot of bantor on Yahoo about the trial supervisor missing a deadline to get into the SF conference in November. Any thoughts about this? I emailed Greg F. this question Thursday and don't have an answer yet.... Have they decided to forego therapeutic dosing in Phase I and do it instead in Phase II?